Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Mol Immunol ; 40(9): 617-31, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14597165

RESUMO

We raised a mouse monoclonal antibody (5S) against the 'a' epitope of the Hepatitis B surface antigen (HBsAg) by selecting for binding of the hybridoma supernatant in conditions that usually destabilize protein-protein interactions. This antibody, which was protective in an in vitro assay, had a high affinity with a relative dissociation constant in the nanomolar range. It also displayed stable binding to antigen in conditions that usually destabilize antigen-antibody interactions, like 30% DMSO, 8 M urea, 4 M NaCl, 1 M guanidium HCl and extremes of pH. The variable regions of the antibody were cloned and expressed as an single chain variable fragment (scFv) (A5). A5 had a relative affinity comparable to the mouse monoclonal and showed antigen binding in presence of 20% DMSO, 8 M urea and 3 M NaCl. It bound the antigen in the pH range of 6-8, though its tolerance for guanidium HCl was reduced. Sequence analysis demonstrated a significant increase in the frequency of somatic replacement mutations in CDRs over framework regions in the light but not in the heavy chain. A comparison of the molecular models of the variable regions of the 5S antibody and its germ-line precursor revealed that critical mutations in the heavy and light chains interface resulted in better inter-chain packing and in the movement of CDR H3 and CDR L1 from their germline positions, which may be important for better antigen binding. In addition to providing a reagent for neutralizing for the virus, such an antibody provides a model for the evolution of stable high affinity interaction during antibody maturation.


Assuntos
Anticorpos Anti-Hepatite B/química , Antígenos de Superfície da Hepatite B/imunologia , Fragmentos de Imunoglobulinas/imunologia , Sequência de Aminoácidos , Anticorpos Monoclonais , Reações Antígeno-Anticorpo , Sequência de Bases , Sítios de Ligação de Anticorpos , Anticorpos Anti-Hepatite B/genética , Hibridomas , Fragmentos de Imunoglobulinas/genética , Modelos Moleculares , Dados de Sequência Molecular , Mutação , Proteínas Recombinantes/imunologia
2.
J Biotechnol ; 99(2): 97-110, 2002 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-12270598

RESUMO

A truncated version of the dengue virus type 2 envelope protein (Den2E) encoding the first 395 amino acid (aa) residues, and Den2E fused in-frame with the full-length 226-aa hepatitis B surface antigen (Den2E-HBsAg) protein were expressed in the methylotrophic yeast, Pichia pastoris. Both the recombinant proteins showed evidence of the capacity to form high molecular weight aggregates. Electron microscopic analysis of the purified proteins showed that while Den2E displayed an amorphous morphology, Den2E-HBsAg existed as well-structured virus-like particles (VLPs). Using immuno-gold electron microscopy, these VLPs were demonstrated to contain both components of the Den2E-HBsAg hybrid protein. Seroanalysis showed that the hybrid VLPs could function in vivo as bivalent immunogens, which could elicit immune responses directed against both components of the hybrid protein, as evidenced by ELISA, immunoprecipitation and immunofluorescence data.


Assuntos
Receptores de Antígenos/imunologia , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/imunologia , Vacinas Sintéticas/biossíntese , Vacinas Sintéticas/imunologia , Proteínas do Envelope Viral/imunologia , Animais , Anticorpos Monoclonais , Expressão Gênica , Camundongos , Camundongos Endogâmicos BALB C , Peso Molecular , Pichia , Receptores de Antígenos/biossíntese , Receptores de Antígenos/genética , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/isolamento & purificação , Vacinas Sintéticas/genética , Proteínas do Envelope Viral/biossíntese , Proteínas do Envelope Viral/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA